Literature DB >> 2874509

Immunoelectron microscopic demonstration of Thy-1 antigen on the surfaces of mesangial cells in the rat glomerulus.

T Yamamoto, K Yamamoto, K Kawasaki, E Yaoita, F Shimizu, I Kihara.   

Abstract

Mesangial cells of F344 rats degenerated and then disappeared within 2 days after the intravenous administration of rabbit antirat thymocyte serum (ATS). Rabbit IgG and rat C3 were identified in the mesangium in the rat glomeruli. To establish the glomerular binding site of ATS administered intravenously into rats, one kidney of each rat given ATS intravenously 12 h earlier was perfused ex vivo through the renal artery with peroxidase-labeled antirabbit IgG followed by sequential glutaraldehyde and diaminobenzidine perfusions to minimize the ultrastructural damage. The other kidney was removed before the perfusion for histologic study to examine the glomerular injury. The rabbit IgG identified by peroxidase-reaction product was present diffusely in the glomerular mesangium when viewed by light microscopy and exclusively on the surfaces of most mesangial cells by electron microscopy. Immunofluorescence microscopy showed rabbit IgG essentially in the mesangium, and electron microscopy revealed the degeneration of mesangial cells in the kidneys that had been removed before the surgical perfusion. However, no histological abnormalities were found in the kidneys from control rats given ATS absorbed with rat thymocytes. The present study showed that the intravenous administration of ATS into rats induced the extensive mesangial cell damage by the binding of ATS to Thy-1 antigens on the mesangial cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874509     DOI: 10.1159/000183857

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  8 in total

1.  Rat mesangial cells actively produce phosphatidylinositol-anchored Thy-1.

Authors:  T Miyata; K Isobe; R Inagi; R Taguchi; H Ikezawa; I Takai; Y Fujita; T Iwamoto; T Hasegawa; O Oda
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

2.  Quantitative study of mesangial injury with proteinuria induced by monoclonal antibody 1-22-3.

Authors:  H Kawachi; T Oite; F Shimizu
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

3.  Progressive renal lesions induced by administration of monoclonal antibody 1-22-3 to unilaterally nephrectomized rats.

Authors:  Q L Cheng; M Orikasa; T Morioka; H Kawachi; X M Chen; T Oite; F Shimizu
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

4.  Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen.

Authors:  H Kawachi; M Orikasa; K Matsui; T Iwanaga; S Toyabe; T Oite; F Shimizu
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

5.  Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injections of monoclonal antibody 1-22-3.

Authors:  H Kawachi; T Iwanaga; S Toyabe; T Oite; F Shimizu
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

6.  Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats.

Authors:  J Floege; E Eng; B A Young; C E Alpers; T B Barrett; D F Bowen-Pope; R J Johnson
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis.

Authors:  L Iruela-Arispe; K Gordon; C Hugo; A M Duijvestijn; K P Claffey; M Reilly; W G Couser; C E Alpers; R J Johnson
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

8.  Determination of the molecular nature and cellular localization of Thy-1 in human renal tissue.

Authors:  T Miyata; K Isobe; R Dawson; M A Ritter; R Inagi; O Oda; R Taguchi; H Ikezawa; I Inoue; H Seo
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.